UVA joins SPARK GLOBAL initiative to accelerate the development of new medicines

The University of Virginia has joined the SPARK GLOBAL initiative to accelerate the development of new medicines and find solutions for the most urgent and complex healthcare challenges of our time.

Mark T. Esser, PhD, head and chief scientific officer of the Manning Institute, UVAPatients are waiting. We understand that time is critical, and joining SPARK GLOBAL connects UVA's exceptional scientists, engineers, clinicians and entrepreneurs with leading experts across academia and industry. This will have huge benefits for our researchers and, ultimately, patients across Virginia and far beyond."

About SPARK

Fast, nimble innovation

SPARK GLOBAL specializes in bridging the gap between academic researchers and industry partners who bring new drugs, devices and treatments to market. It offers access to new funding sources, to world-class mentorship and educational opportunities and to highly specialized technical expertise in drug and diagnostic development. The goal is to break down barriers that slow progress and accelerate development of what SPARK GLOBAL calls "tangible healthcare solutions" that benefit patients.

"SPARK GLOBAL shares UVA and UVA Health's commitment to putting patients first and developing the medicines and cures they need," Esser said. "We are excited to be part of this incredible program and look forward to the lifesaving and life-changing advances we will produce together."

Source:

University of Virginia Health System